Trial NCT05545319

View at ClinicalTrials.gov 
Org. Study IDs: C4671031
Secondary IDs: 2022-002447-22

Last trial update was posted on 2023-03-01

MeSH Interventions

Nirmatrelvir Ritonavir

MeSH Conditions

COVID-19 Coronavirus Infections Severe Acute Respiratory Syndrome

Other Conditions

Child, Hospitalized Coronavirus Disease 2019 (COVID-19) Hospitalization Immunocompromised Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Stopping Reasons

Termination due to challenges related to the operational feasibility of the study, taking into account the current epidemiology and declining hospitalization rates for severe COVID-19.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID